Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02579265
Recruitment Status : Recruiting
First Posted : October 19, 2015
Last Update Posted : February 6, 2019
Sponsor:
Information provided by (Responsible Party):
Fresenius Kabi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : October 2019